favipiravir - Fresh Lime Soda

On The Lancet editorial

May 19, 2021 2 min read

On May 8, The Lancet published an editorial criticising the Narendra Modi government's response to India's second COVID-19 outbreak, which has been redefining the meaning of 'snafu'. A…

Spray and pray – the COVID-19 version

Sep 2, 2020 2 min read

Science azithromycin Biocon chyavanprash COVID-19 cytokine release syndrome cytokine storm favipiravir hydroxychloroquine Itolizumab Kiran Mazumdar-Shaw novel coronavirus psoriasis The Print

Kiran Mazumdar-Shaw is the head of Biocon, a company headquartered in Bengaluru and which has repurposed a drug called itolizumab – already approved to help manage severe chronic psoriasis in differen…

India's missing research papers

Aug 9, 2020 2 min read

Science Bharat Biotech Biocon Covaxin COVID-19 COVID-19 epidemic COVID-19 pandemic ELISA test kit favipiravir hydroxychloroquine Indian Council of Medical Research Itolizumab novel coronavirus peer review preprint papers remdesivir science academies science by press release seroprevalence survey Tata Institute of Fundamental Research tocilizumab Zydus Cadila

If you're looking for a quantification (although you shouldn't) of the extent to which science is being conducted by press releases in India at the moment, consider the following list of studi…